Patents Assigned to University
  • Patent number: 6703213
    Abstract: General methods for monitoring the activity of MurG, a GlcNAc transferase involved in bacterial cell wall biosynthesis, is disclosed. More particularly, the synthesis of simplified substrate analogs of Lipid I (the natural substrate for MurG), which function as acceptors for UDP-GlcNAc in an enzymatic reaction catalyzed by MurG, is described. Assays using the substrate analogs of the invention are further disclosed, which are useful for identifying a variety of other substrates, including inhibitors of MurG activity, for facilitating mechanistic and/or structural studies of the enzyme and for other uses. High throughput assays are also described.
    Type: Grant
    Filed: April 22, 2002
    Date of Patent: March 9, 2004
    Assignee: The Trustees of Princeton University
    Inventors: Suzanne Walker Kahne, Hongbin Men, Peter Park, Min Ge
  • Patent number: 6702875
    Abstract: Described are filters containing free-activated carbon fibers or activated carbon fibers in the form of a composite used for filtering a variety of contaminants, including pathogens, from air. These filters can provide effective and efficient removal of contaminants from air, requiring only short contact time between the air being filtered and the filter itself, with only a minimum pressure drop across the filter. The characteristics of these filters allow for effective filtration with only thin filter layers being required. The process of filtering air utilizing these filters is also disclosed.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: March 9, 2004
    Assignee: University of Kentucky Research Foundation
    Inventors: Marit Jagtoyen, Francis John Derbyshire
  • Patent number: 6703406
    Abstract: Compounds used for treating dependence on or withdrawal from a drug of abuse, for an eating disorder or for a CNS disease or pathology having the following formulas:
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: March 9, 2004
    Assignee: University of Kentucky Research Foundation
    Inventors: Peter A. Crooks, Linda Dwoskin, Dennis Keith Miller, Vladimir P. Grinevich, Seth Davin Norrholm, Guangrong Zheng
  • Patent number: 6703518
    Abstract: Chelating monomers and fluoride-releasing compositions are disclosed that may be incorporated into dental composite restorative materials or other dental materials, to produce materials with high fluoride release rates, and high fluoride recharge capability. Such resins may be used in dental restorative materials to help reduce the level of dental caries in patients, particularly the level of caries occurring on the margins of the restorative materials.
    Type: Grant
    Filed: March 5, 2003
    Date of Patent: March 9, 2004
    Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Xiaoming Xu, John O. Burgess, Xingzhe Ding, Long Ling
  • Patent number: 6702756
    Abstract: A method of diagnosing neurological impairments such as multiple sclerosis includes the determination of the simultaneity threshold of a pair of sensory stimuli, such as visual or tactile stimuli, separated temporally by a stimulus onset asynchrony (SOA). The stimuli may be presented unilaterally or bilaterally. Interhemispheric transfer times may also be determined by determining the difference in simultaneity thresholds for bilateral and unilateral presentations. Simultaneity thresholds and interhemispheric transfer times are significantly elevated in patients with MS and other neurological impairments. An apparatus for delivering such sensory stimuli includes an array of visual stimuli and tactile stimulators, a computer-implemented control program and a precise timing mechanism.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: March 9, 2004
    Assignee: University Technologies International Inc.
    Inventor: Lenora Brown
  • Patent number: 6703206
    Abstract: An immunological assay and kit for colon cancer screening is disclosed. Fecal glycoproteins are extracted from individual samples such that immunogenicity is maintained. The purified fecal glycoproteins are reacted with antibodies to Colon and Ovarian Tumor Antigen (COTA). The mucin antigen COTA is specifically present in colorectal cancer tissue and not in normal colons. The amount of COTA in the fecal sample is determined and used to indicate the presence of colon cancer.
    Type: Grant
    Filed: July 25, 2001
    Date of Patent: March 9, 2004
    Assignee: Loma Linda University Adventist Health Sciences Center
    Inventors: Keshab D. Pant, John D. McCracken, Omar Fagoaga, Wayne Kelln, Sandra Nehlsen-Cannarella
  • Patent number: 6703216
    Abstract: Methods, compositions and articles of manufacture for assaying a sample for a GHB source are provided. A sample suspected of containing a GHB source is contacted with a first oxidoreductase selective for GHB and an oxidized cofactor. In the presence of GHB in the sample, the first oxidoreductase oxidizes GHB to succinic semialdehyde and reduces the cofactor. The reduced cofactor thus produced can be detected directly, or a hydride abstractor can be used that abstracts a hydride from the reduced cofactor and produces a detectable change. The hydride abstractor can be a second oxidoreductase that oxidizes the reduced cofactor and produces a detectable change in a chromogen or dye. Preferably a visual change is produced, allowing performance of the assay outside of a laboratory setting. Fusion proteins comprising the first oxidoreductase, polynucleotides encoding such proteins, host cells expressing such proteins, and vectors comprising such polynucleotides are also provided.
    Type: Grant
    Filed: March 14, 2002
    Date of Patent: March 9, 2004
    Assignee: The Regents of the University of California
    Inventors: Stanley M. Parsons, David O. Harris, Dawn T. Bravo
  • Patent number: 6704341
    Abstract: A laser wherein pump radiation from laser diodes is delivered to a pump chamber and into the lasing medium by quasi-three-dimensional compound parabolic concentrator light channels. The light channels have reflective side walls with a curved surface and reflective end walls with a curved surface. A flow tube between the lasing medium and the light channel has a roughened surface.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: March 9, 2004
    Assignee: The Regents of the University of California
    Inventor: Jim J. Chang
  • Patent number: 6703660
    Abstract: The present invention concerns an electrical junction between one transistor and at least one voltage sensitive cell such as a neuron. The invention further concerns transistors to be used in said junction and methods for their preparation. By another aspect the invention concerns “an artificial chemical synapse” i.e. a junction between a cell, which secretes an agent, and a transistor bearing receptors for the agent, wherein binding of the agent to the receptor changes an electrical property off the transistor.
    Type: Grant
    Filed: August 22, 2001
    Date of Patent: March 9, 2004
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Shlomo Yitzchaik, Joseph Shappir, Micha Spira
  • Patent number: 6701704
    Abstract: A method of processing textile material is disclosed in which the material (13) is passed along a predetermined path through a liquid jet device (50, 70, 80, 90, 100, 120, 130) applying a force to the material (13) transversely to the axis of the material (13). High pressure water is used to form one or more belts (11, 12) for applying twist to a yarn (13), sliver or roving (273), or as a jet to intermingle one or more yarns (13). The water may serve to cool the yarn (13) after beating in a false twist process.
    Type: Grant
    Filed: January 7, 2002
    Date of Patent: March 9, 2004
    Assignee: University of Manchester Institute of Science and Technology
    Inventors: Peter William Foster, Duncan Cameron Ferrier, Ujithe Sujeewa Wickramasinghe Gunasekera
  • Patent number: 6701760
    Abstract: A tool for remotely turning a key includes a key unit including an engagement assembly adapted to engage the key and an operator unit including a control assembly. At least one cable segment is provided linking the key unit and the operator unit such that the engagement assembly can be mechanically rotated via the cable segment by manipulation of the control assembly to thereby rotate the key when the key is engaged by the engagement assembly.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: March 9, 2004
    Assignee: Universal Product Marketing, Inc.
    Inventor: John Elliason
  • Patent number: 6703034
    Abstract: A method of forming an oil in water microemulsion includes the steps of providing at least one non-ionic ethoxylated surfactant, providing an oil and mixing the surfactant and the oil to form a microemulsion. The surfactant can be selected from the group of alkyl phenol ethoxylates, where the alkyl group contains 8 to 12 carbons and the ethoxylate contains an average of 4 to 12 ethoxylate groups. The surfactant can be a nonyl phenol ethoxylate. An oil in water microemulsion includes at least one non-ionic ethoxylated surfactant and at least one oil. The surfactant can be a single surfactant or a mixed surfactant. The oil can be derived from at least one tree, preferably from as the Neem Tree.
    Type: Grant
    Filed: December 10, 2001
    Date of Patent: March 9, 2004
    Assignee: University of Florida
    Inventors: Balraj S. Parmar, Manoj Varshney, Dinesh O. Shah
  • Patent number: 6703611
    Abstract: An electrospray ionization device is provided that includes one or more electrospray needles and an ion sampling device. Each needle has a distal end for receiving a sample, a tip for spraying the sample in fluid communication with the distal end, and an electrical contact for contacting at least some portion of sample therein. The ion sampling device has an entrance, an exit, and an interior in fluid communication with the entrance and the exit, and is located in proximity to the tip or tips of the one or more electrospray needles. The entrance defines an opening that has a larger area than an opening defined by the exit. The ion sampling device also has a counter-electrical contact. The electrospray ionization device further comprises means for generating an electrical potential difference between the counter-electrical contact and the electrical contact(s) of the one or more electrospray needles.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: March 9, 2004
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Gary L. Glish, Ryan M. Danell
  • Patent number: 6702993
    Abstract: Mesoporous hexagonal, cubic or wormhole aluminosilicates derived from zeolite seeds using an ionic structure directing agent are described. The aluminum in the structures is stable so that the framework of the structures does not collapse when heated in the presence of water or water vapor (steam). The steam stable aluminosilicates can be used as acid catalysts for hydrocarbon conversions, including the fluidized bed catalytic cracking and the hydrocracking of petroleum oils, and other cracking of organic compounds.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: March 9, 2004
    Assignee: Board of Trustees of Michigan State University
    Inventors: Thomas J. Pinnavaia, Wenzhong Zhang, Yu Liu
  • Patent number: 6702989
    Abstract: A gas chromatography system having a computer-controlled venting valve system that delivers pressurized pulses to a column junction point of two series-coupled columns having different stationary-phase chemistries and a method of using the same. Each pressurized pulse causes a differential change in the carrier gas velocities in the two columns, which lasts for the duration of the pressurized pulse. Whereby, the pressurized pulse selectively increases the separation of a component pair that exhibits separation at the exit of the first column, but otherwise co-elutes from the column ensemble.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: March 9, 2004
    Assignee: The Regents of the University of Michigan
    Inventors: Richard Douglas Sacks, Joshua Jonathan Mark Whiting
  • Patent number: 6703426
    Abstract: Compounds of the class of 4-oxo-butenoic acid derivatives are disclosed along with the surprising use property of these compounds as a anti-tumor agents in humans against breast carcinoma, which include: 2-(N′-Fluoren-9-ylidene-hydrazino)5,5-dimethyl-4-oxo-hex-2-enoic acid methyl ester (OF-06), 1-(2,4-Dimethyl-phenyl)-2,4-dihydroxy-3-(4-methyl-benzoyl)-5-oxo-2,5-dihydro-1H-pyrrole-2-carboxylic acid methyl ester (1F-07), 4-(4-Methoxy-phenyl)-2,4-dioxo-3-(phenyl-hydrazono)-butyric acid (3F-10), 4-(4-Chloro-phenyl)-2,4-dioxo-3-(phenyl-hydrazono)-butyric acid ethyl ester (3F-11), 2-Hydroxy-4-oxo-4-(2,3,5,6-tetrafluoro-4-methoxy-phenyl)-but-2-enoic acid (3F-15), and 4,4-Dihydroxy-5-(4-methyl-benzoyl)-2-phenyl-2,4-dihydro-pyrazol-3-one (3F-16) as well as some novel derivatives of these compounds claimed (see Table 2).
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: March 9, 2004
    Assignee: University of Central Florida
    Inventors: D. Howard Miles, Solodnikov Sergey Yurjevich, Krasnykh Olga Petrovna, Pimenova Elena Valentinovna, Elena A. Goun
  • Patent number: 6703414
    Abstract: A method of inhibiting restenosis in a subject following coronary angioplasty, atherectomy, or arterial bypass graft surgery comprised of administering wortmannin analogs of the present invention is described herein.
    Type: Grant
    Filed: September 16, 2002
    Date of Patent: March 9, 2004
    Assignee: Arizona Board of Regents on behalf of the University of Arizona
    Inventors: Garth Powis, Robert Abraham
  • Patent number: 6703482
    Abstract: Peptides having general and specific binding affinities for the Src homology region 3 (SH3) domains of proteins are disclosed in the present invention. In particular, SH3 binding peptides have been isolated from three phage-displayed random peptide libraries which had been screened for isolates that bind to bacterial fusion proteins of SH3 domains and glutathione S-transferase (GST). Preferred peptides are disclosed having a core 7-mer sequence (preferably, a consensus motif) and two or more, preferably at least six, additional amino acid residues flanking the core sequence, for a total length of 9, preferably at least 13, amino acid residues and no more than about 45 amino acid residues. Such peptides manifest preferential binding affinities for certain SH3 domains. The preferred peptides exhibit specific binding affinities for the Src-family of proteins. In vitro and in vivo results are presented which demonstrate the biochemical activity of such peptides.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: March 9, 2004
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Brian K. Kay, Andrew B. Sparks, Judith M. Thorn, Lawrence A. Quilliam, Channing J. Der
  • Patent number: 6703904
    Abstract: A high frequency oscillator for combining outputs of two oscillator to generate an oscillation output. The oscillators has a substrate, a slot line formed on a first main plane of the substrate and having both longitudinal ends, the both longitudinal ends being electrically short-circuited, a first and a second amplifier for oscillation, each disposed on one and the other side of the slot line, and having outputs of the same oscillation frequency, and an unbalanced transmission line for connecting input terminals of the first and second amplifiers to each other and for connecting output terminals of the first and second amplifiers to each other. The unbalanced transmission line traverses the slot line and forms a closed loop including the first and second amplifiers.
    Type: Grant
    Filed: September 13, 2002
    Date of Patent: March 9, 2004
    Assignees: Nihon Dempa Kogyo Co., LTD, Saga University
    Inventors: Masayoshi Aikawa, Fumio Asamura, Takeo Oita
  • Patent number: RE38459
    Abstract: An injectable physiologically acceptable aqueous phase fluorocarbon emulsion, which has substantially no free fluorocarbon, has an excellent stability is prepared by a process of the invention. Typically, more than about 99.8 wt. % of the fluorocarbon remains in the size range of about 0.2 to 0.4 microns even after being stored at room temperature for one year or more in sealed containers under a non-oxidizing atmosphere. The emulsion is useful in medical applications, for example, coronary angioplasty, cancer therapy, among others.
    Type: Grant
    Filed: January 21, 1999
    Date of Patent: March 9, 2004
    Assignee: Thomas Jefferson University
    Inventors: Stuart Raynolds, Robert H. Dettre